Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Chiang Mai Ram Medical Business PCLBKK:CMR +0.79%36 Return-on-Tangible-Equity is 2.88% as of Mar. 2026, which is 71% below its 10-year median of 9.79. GuruFocus rates BKK:CMR with a GF Score™ of 36/100 and a GF Value™ of ฿0.77 (Significantly Overvalued). The stock has 9 warning signs investors should review. Among 577 Healthcare Providers & Services companies, Chiang Mai Ram Medical Business PCL ranks better than 84.58% on this metric.
The historical rank and industry rank for Chiang Mai Ram Medical Business PCL's Return-on-Tangible-Equity or its related term are showing as below:
BKK:CMR'
s Return-on-Tangible-Equity Range Over the Past 10 Years
Min: 3.48 Med: 9.79 Max: 69.34
Current: 69.34
During the past 13 years, Chiang Mai Ram Medical Business PCL's highest Return-on-Tangible-Equity was 69.34%. The lowest was 3.48%. And the median was 9.79%.
BKK:CMR's Return-on-Tangible-Equity is ranked better than 84.58% of 577
companies
in the Healthcare Providers & Services industry
Industry Median: 10.13
vs BKK:CMR: 69.34
Chiang Mai Ram Medical Business PCL (BKK:CMR) Return-on-Tangible-Equity Explanation
Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.
Be Aware
Net Income is used.
Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.
Chiang Mai Ram Medical Business PCL Return-on-Tangible-Equity Related Terms
Chiang Mai Ram Medical Business PCL Return-on-Tangible-Equity Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Chiang Mai Ram Medical Business PCL Return-on-Tangible-Equity Chart
BKK:CMR vs HCA, THC, DVA: Return-on-Tangible-Equity Comparison
For the Medical Care Facilities subindustry, Chiang Mai Ram Medical Business PCL's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Chiang Mai Ram Medical Business PCL Return-on-Tangible-Equity vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Chiang Mai Ram Medical Business PCL's Return-on-Tangible-Equity distribution charts can be found below:
* The bar in red indicates where Chiang Mai Ram Medical Business PCL's Return-on-Tangible-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is four times the quarterly (Mar. 2026) net income data.
Return-on-Tangible-Equity is displayed in the 10-year financial page.
What does a Return-on-Tangible-Equity of 2.88% mean?
Chiang Mai Ram Medical Business PCL (BKK:CMR) has a Return-on-Tangible-Equity of 2.88% as of Mar. 2026. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Chiang Mai Ram Medical Business PCL and its competitors. This is 71% below median its historical median of 9.79. Over the past decade, Chiang Mai Ram Medical Business PCL's Return-on-Tangible-Equity has ranged from 3.48 to 69.34. According to the industry distribution chart, Chiang Mai Ram Medical Business PCL ranks #89 out of 577 companies in the Healthcare Providers & Services industry, placing it in the top 15.4%.
Is Chiang Mai Ram Medical Business PCL's Return-on-Tangible-Equity too high?
Chiang Mai Ram Medical Business PCL's current Return-on-Tangible-Equity of 2.88% is 71% below median its 10-year median of 9.79. Over the past 10 years, this metric has ranged from a low of 3.48 to a high of 69.34. The Healthcare Providers & Services industry median Return-on-Tangible-Equity is 10.13. Chiang Mai Ram Medical Business PCL's value of 2.88% is 71.6% below this industry median. Based on the distribution chart, Chiang Mai Ram Medical Business PCL ranks #89 out of 577 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Chiang Mai Ram Medical Business PCL has a GF Score™ of 36/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Chiang Mai Ram Medical Business PCL's Return-on-Tangible-Equity compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Chiang Mai Ram Medical Business PCL ranks #89 out of 577 companies for Return-on-Tangible-Equity. This places Chiang Mai Ram Medical Business PCL in the top 15% of its industry — outperforming the majority of peers. The industry median Return-on-Tangible-Equity is 10.13. Chiang Mai Ram Medical Business PCL's value of 2.88% is 71.6% below this benchmark. Historically, Chiang Mai Ram Medical Business PCL's own Return-on-Tangible-Equity has ranged from 3.48 to 69.34 over the past decade. While the company's 10-year median is 9.79 vs. the industry median of 10.13, Chiang Mai Ram Medical Business PCL has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Equity for a Healthcare Providers & Services company?
The median Return-on-Tangible-Equity among Healthcare Providers & Services companies is 10.13, based on 577 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Equity significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Chiang Mai Ram Medical Business PCL's current Return-on-Tangible-Equity of 2.88% is 71.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Equity mean?
A high Return-on-Tangible-Equity can signal that a stock is expensive relative to its fundamentals. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Chiang Mai Ram Medical Business PCL and its competitors. For the Healthcare Providers & Services industry, the median Return-on-Tangible-Equity is 10.13 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Chiang Mai Ram Medical Business PCL's current Return-on-Tangible-Equity is 2.88%, which is 71% below median its own 10-year median of 9.79. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Chiang Mai Ram Medical Business PCL stock overvalued right now?
Based on GuruFocus' analysis, Chiang Mai Ram Medical Business PCL (BKK:CMR) is currently considered Significantly Overvalued. The stock's GF Value™ is ฿0.77, compared to a current price of ฿1.27 — trading 64.9% above its estimated fair value. The current Return-on-Tangible-Equity is 2.88%, which is 71% below median its 10-year median of 9.79 and 71.6% below the Healthcare Providers & Services industry median of 10.13. Chiang Mai Ram Medical Business PCL's overall GF Score™ is 36/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Equity calculated?
Return-on-Tangible-Equity is calculated from a company's financial statements. For Chiang Mai Ram Medical Business PCL (BKK:CMR), the current Return-on-Tangible-Equity is 2.88% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Chiang Mai Ram Medical Business PCL (BKK:CMR) Overvalued in 2026?
Based on GuruFocus' analysis, Chiang Mai Ram Medical Business PCL stock appears to be overvalued.
The current stock price of ฿1.27 is trading 64.9% above its estimated GF Value™ of ฿0.77.
GuruFocus considers Chiang Mai Ram Medical Business PCL to be Significantly Overvalued.
Key valuation signals for BKK:CMR:
Return-on-Tangible-Equity: 2.88% (71% below median its 10-year median of 9.79)
GF Value™: ฿0.77 vs. price of ฿1.27 (64.9% above fair value)
Industry Position: 71.6% below the Healthcare Providers & Services median (#89 of 577)
No single metric tells the full story. See the BKK:CMR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Chiang Mai Ram Medical Business PCL Business Description
Chiang Mai Ram Medical Business PCL is a Thailand-based company. It provides medical services in the nature of General Hospital, Hospital in Social Security, and the national health security office systems. It offers various medical services including a Dental center, X-ray mobile for a checkup, CT Multislice, Cardiac Catheterization Center, Back pain center, Gynecologic Cancer center, Physical therapy, Operating theatres, Laboratory, Ambulance Services, and Health checkup center, and others. The company provides medical services through the Lanna Hospital.
36GF Score
Get the complete analysis for BKK:CMR
Return-on-Tangible-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BKK:CMR has been successfully added to your 
